Chutes & Ladders—Sanofi CSO steps down
Chutes & Ladders—Sanofi CSO steps down mbayer Thu, 05/09/2024 - 15:42
Chutes & Ladders—Sanofi CSO steps down mbayer Thu, 05/09/2024 - 15:42
Rallybio reins in preclinical R&D, while Monopar pivots to radiopharma to eke out cash ntaylor Thu, 05/09/2024 - 10:14
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes jwaldron Thu, 05/09/2024 - 06:24
Takeda culls cancer, gut and inflammation drugs in R&D rethink ntaylor Thu, 05/09/2024 - 05:15
Regeneron's cell medicines chief is crafting a new cell therapy 'secret sauce' aarmstrong Wed, 05/08/2024 - 21:50
FDA partners with other agencies to outline new plan for biotech product regulation hfloersh Wed, 05/08/2024 - 18:41